We are live on ! Find out more

14 hedge funds and large institutions have $829K invested in PAVmed in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

56% more funds holding

Funds holding: 914 (+5)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.02% less ownership

Funds ownership: 0.02%0.01% (-0.02%)

51% less capital invested

Capital invested by funds: $1.69M → $829K (-$860K)

Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
2
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

PAVM Hedge Fund Activity: Q3 2018 in Review

14 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q3 2018, worth a combined $829K — down 51% from $1.69M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PAVM positions and 4 closed out — a net gain of 5 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $373K. The largest seller was Sabby Management, exiting entirely with an estimated $1.33M sold.

  • 14 institutional investors held PAVmed (PAVM) as of Q3 2018, up from 9 in Q2 2018.
  • Funds reported $829K of PAVmed stock for Q3 2018, down 51% quarter-over-quarter.
  • 9 funds opened new PAVmed positions in Q3 2018 and 4 closed out, a net change of +5 holders.
  • The largest PAVmed buyer in Q3 2018 was Vanguard Group, an estimated $373K added.
  • The largest PAVmed seller in Q3 2018 was Sabby Management, an estimated $1.33M sold.

Based on aggregated 13F filings for Q3 2018.